The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.
作者信息
Möller Hans-Jürgen
机构信息
Department of Psychiatry, University of Munich, Germany.
出版信息
World Psychiatry. 2008 Feb;7(1):35-6. doi: 10.1002/j.2051-5545.2008.tb00148.x.
Abstract
摘要
相似文献
1
The assessment of cognitive impairment would be a relevant addition to the criteria for diagnosing schizophrenia.认知障碍的评估将是精神分裂症诊断标准的一个相关补充。
World Psychiatry. 2008 Feb;7(1):35-6. doi: 10.1002/j.2051-5545.2008.tb00148.x.
2
Should cognitive impairment be included in the diagnostic criteria for schizophrenia?认知障碍是否应纳入精神分裂症的诊断标准？
World Psychiatry. 2008 Feb;7(1):22-8. doi: 10.1002/j.2051-5545.2008.tb00142.x.
3
Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).与精神病相关的认知障碍（CIAPs）的一组临床标准的有效性和实用性。
Psychiatry Res. 2020 Nov;293:113404. doi: 10.1016/j.psychres.2020.113404. Epub 2020 Aug 18.
4
How should DSM-V criteria for schizophrenia include cognitive impairment?《精神疾病诊断与统计手册》第五版中精神分裂症的标准应如何纳入认知障碍？
Schizophr Bull. 2007 Jul;33(4):912-20. doi: 10.1093/schbul/sbm046. Epub 2007 Jun 13.
5
A pilot study to measure cognitive impairment in patients with severe schizophrenia with the Montreal Cognitive Assessment (MoCA).一项使用蒙特利尔认知评估量表（MoCA）测量重度精神分裂症患者认知功能损害的初步研究。
Schizophr Res. 2014 Sep;158(1-3):151-5. doi: 10.1016/j.schres.2014.07.006. Epub 2014 Aug 1.
6
[The association between cognitive deficits and different outcomes of schizophrenia].[认知缺陷与精神分裂症不同结局之间的关联]
Psychiatr Pol. 2014 Nov-Dec;48(6):1087-104. doi: 10.12740/PP/37438.
7
Evidence that communication impairment in schizophrenia is associated with generalized poor task performance.有证据表明，精神分裂症中的沟通障碍与整体任务表现不佳有关。
Psychiatry Res. 2017 Mar;249:172-179. doi: 10.1016/j.psychres.2016.12.051. Epub 2017 Jan 6.
8
Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review.蒙特利尔认知评估用于评估精神分裂症患者的认知障碍：系统评价。
Gen Hosp Psychiatry. 2020 Jul-Aug;65:64-73. doi: 10.1016/j.genhosppsych.2020.05.011. Epub 2020 May 29.
9
Senile degeneration and cognitive impairment in chronic schizophrenia.慢性精神分裂症中的老年退化与认知障碍
Am J Psychiatry. 1998 Nov;155(11):1536-43. doi: 10.1176/ajp.155.11.1536.
10
Measuring stability of cognitive impairment in inpatients with schizophrenia with alternate forms of the Montreal Cognitive Assessment during acute hospitalization.在急性住院期间，使用蒙特利尔认知评估的交替形式来衡量精神分裂症住院患者认知障碍的稳定性。
Psychiatry Res. 2017 Dec;258:299-304. doi: 10.1016/j.psychres.2017.08.065. Epub 2017 Aug 24.
引用本文的文献
1
The forthcoming revision of the diagnostic and classificatory system: perspectives based on the European psychiatric tradition.即将到来的诊断与分类系统修订：基于欧洲精神病学传统的视角
Eur Arch Psychiatry Clin Neurosci. 2008 Nov;258 Suppl 5:7-17. doi: 10.1007/s00406-008-5004-4.
2
Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.分类法与维度法之间的精神疾病系统研究：克雷佩林二分法及其他。
Eur Arch Psychiatry Clin Neurosci. 2008 Jun;258 Suppl 2:48-73. doi: 10.1007/s00406-008-2004-3.
本文引用的文献
1
Plexin B3 is genetically associated with verbal performance and white matter volume in human brain.丛状蛋白B3在基因上与人脑的语言能力和白质体积相关。
Mol Psychiatry. 2007 Feb;12(2):190-4, 115. doi: 10.1038/sj.mp.4001903. Epub 2006 Oct 10.
2
Intermediate phenotypes and genetic mechanisms of psychiatric disorders.精神疾病的中间表型与遗传机制
Nat Rev Neurosci. 2006 Oct;7(10):818-27. doi: 10.1038/nrn1993.
3
Problems associated with the classification and diagnosis of psychiatric disorders.与精神疾病分类和诊断相关的问题。
World J Biol Psychiatry. 2005;6(1):45-56. doi: 10.1080/15622970510029830.
4
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.美国食品药品监督管理局（FDA）-美国国立精神卫生研究所（NIMH）-精神分裂症临床试验测量与研究国际联盟（MATRICS）关于精神分裂症神经认知药物临床试验设计研讨会综述
Schizophr Bull. 2005 Jan;31(1):5-19. doi: 10.1093/schbul/sbi020. Epub 2005 Feb 16.
5
M129V variation in the prion protein may influence cognitive performance.
Mol Psychiatry. 2003 Nov;8(11):937-41. doi: 10.1038/sj.mp.4001327.
6
[Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].
Nervenarzt. 2003 Sep;74(9):762-6. doi: 10.1007/s00115-002-1434-9.
7
Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.新型/非典型抗精神病药物的定义、精神药理学基础及临床评估：方法学问题与临床后果
World J Biol Psychiatry. 2000 Apr;1(2):75-91. doi: 10.3109/15622970009150570.
Zotero 插件